As a paediatric rheumatologist, I have encountered various cases of hereditary angioedema (HAE) in my practice. This rare, yet potentially life-threatening condition affects about 1 in 10,000 to 1 ...

The worldwide market for hereditary angioedema (HAE) is estimated at $500 million, and the space is attracting buyers. Shire, of Basingstoke, UK, announced in early July that it was buying Jerini ...

Patients in England and Wales with hereditary angioedema (HAE) should soon have a new treatment option after NICE recommended Takeda’s Takhzyro (lanadelumab) should be funded by the NHS in the ...

Shire plans to file its lanadelumab for the rare genetic disorder, hereditary angioedema (HAE), on the back of new phase 3 data showing the drug reduces monthly swelling attacks when taken as a ...

That’s how my parents knew that I had hereditary angioedema (HAE) – a rare disease that I’d inherited from my dad. HAE is caused by a deficiency in C1 inhibitor (C1-INH) in the blood and it ...

Firazyr (Icatibant) is a selective, competitive bradykinin B2 receptor antagonist indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

A single treatment with, a CRISPR-Cas9-based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe ...

Chloe Davies, 32, who lives in Bristol, has hereditary angioedema (HAE), which causes "spontaneous swelling attacks". "If my hand swelled up it would just keep going and going. Severe attacks can ...